Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome
Clinical trial NCT05528705 · COMPLETED
Trial details
- NCT number
- NCT05528705
- Sponsor
- Green Cross Wellbeing
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2023-10-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.